ExodusPoint Capital Management’s Evofem Biosciences, Inc. Common Stock EVFM Stock Holding History

ExodusPoint Capital Management’s Portfolio EVFM Stock Details EVFM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q3	–	Sell	-7,892	Closed	-$134K	–	2875
2021 Q2	$134K	Buy	7,892 +6,889	+687%	+$131K	﹤0.01%	2088
2021 Q1	$26K	Buy	+1,003	New	+$45.6K	﹤0.01%	2053
2020 Q2	–	Sell	-1,358	Closed	-$108K	–	2124
2020 Q1	$108K	Buy	+1,358	New	+$109K	0.01%	883

Other funds holding EVFM

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

BBA

Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return

FWSM

First Wilshire Securities Management Pasadena, California $444M AUM 42.88% 1-Year Est. Return

Fuller & Thaler Asset Management San Mateo, California $29.7B AUM 43.33% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Group One Trading Chicago, Illinois $52.2B AUM 104.56% 1-Year Est. Return

ExodusPoint Capital Management's EVFM Position: Q3 2021 in Review

ExodusPoint Capital Management sold out of Evofem Biosciences, Inc. Common Stock (EVFM) in Q3 2021, closing a stake of 7,892 shares — an estimated $134K sold.

ExodusPoint Capital Management first reported a position in EVFM in Q1 2020 and held it in 3 quarters. The position peaked at $134K in Q2 2021. 71 funds tracked by Wall St. Rank hold EVFM as of Q3 2021.

ExodusPoint Capital Management reported no remaining Evofem Biosciences, Inc. Common Stock position as of Q3 2021 after selling out during the quarter.
ExodusPoint Capital Management sold 7,892 Evofem Biosciences, Inc. Common Stock shares in Q3 2021, an estimated $134K.
ExodusPoint Capital Management first reported a position in Evofem Biosciences, Inc. Common Stock in Q1 2020 and held it in 3 quarters.
ExodusPoint Capital Management's Evofem Biosciences, Inc. Common Stock position peaked at $134K in Q2 2021.
71 funds tracked by Wall St. Rank held Evofem Biosciences, Inc. Common Stock as of Q3 2021.

Based on ExodusPoint Capital Management's 13F filing for Q3 2021, filed 15 Nov 2021.